医学
怀孕
工作队
妊娠高血压
血压
产科
高血压病
人口
慢性高血压
子痫前期
儿科
内科学
环境卫生
公共行政
生物
遗传学
政治学
作者
Michael J. Barry,Wanda K. Nicholson,Michael Silverstein,Michael D. Cabana,David Chelmow,Tumaini R. Coker,Esa M. Davis,Katrina E Donahue,Carlos Roberto Jaén,Li Li,Gbenga Ogedegbe,Goutham Rao,John Ruiz,James Stevermer,Joel Tsevat,Sandra Millon Underwood,John B. Wong
出处
期刊:JAMA
[American Medical Association]
日期:2023-09-18
卷期号:330 (11): 1074-1074
被引量:56
标识
DOI:10.1001/jama.2023.16991
摘要
Importance Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10 000 deliveries in 1993 to 1021 cases per 10 000 deliveries in 2016 to 2017. Objective The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. Population Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. Evidence Assessment The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. Recommendation The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation)
科研通智能强力驱动
Strongly Powered by AbleSci AI